All Stories

  1. Strategies to Overcome Hematocrit and Volume Bias in Dried Blood Spot Analysis

    Article • Pharmaceuticals, March 2026, MDPI AG

    Tomaž Vovk

  2. Volumetric absorptive microsampling for lumateperone analysis: method validation and stability evaluation

    Article • Analytical and Bioanalytical Chemistry, November 2025, Springer Science + Business Media

    Dr. Michele Protti, Professor Roberto Mandrioli, Associate Prof. Dr. Laura Mercolini, Tomaž Vovk

  3. Oxidative Stress-Related Biomarkers in Inflammatory Bowel Disease: Dual Tools for Remission Assessment and Prediction of Treatment Outcome

    Article • Antioxidants, September 2025, MDPI AG

    Tomaž Vovk

  4. Clinical pharmacist interventions in medication review for medication optimization in older hospitalized adults with mental disorders and somatic comorbidities: evidence from retrospective study

    Article • Frontiers in Pharmacology, September 2025, Frontiers

    Tomaž Vovk

  5. Development, Validation and Application of the Dried Blood Spot Analysis Method for the Determination of Ustekinumab in Patients with Inflammatory Bowel Disease

    Article • Pharmaceuticals, August 2025, MDPI AG

    Tomaž Vovk

  6. Navigating Vancomycin and Acute Kidney Injury: AUC- vs. Trough-Guided Monitoring in Initial and Steady-State Therapy

    Article • Antibiotics, April 2025, MDPI AG

    Tomaž Vovk

  7. Assessment of Extracellular Particles Directly in Diluted Plasma and Blood by Interferometric Light Microscopy. A Study of 613 Human and 163 Canine Samples

    Article • Cells, December 2024, MDPI AG

    Tomaž Vovk

  8. Oxidative stress-related biomarkers as promising indicators of inflammatory bowel disease activity: A systematic review and meta-analysis

    Article • Redox Biology, November 2024, Elsevier

    Tomaž Vovk

  9. A Cross-Sectional Study Comparing Oxidative Stress in Patients with Epilepsy Treated with Old and New Generation Antiseizure Medications

    Article • Medicina, August 2024, MDPI AG

    Tomaž Vovk

  10. Supplementation of vitamin E as an addition to a commercial renal diet does not prolong survival of cats with chronic kidney disease

    Article • BMC Veterinary Research, July 2024, Springer Science + Business Media

    Tomaž Vovk

  11. An LC-MS/MS Method for Quantification of Lamotrigine and Its Main Metabolite in Dried Blood Spots

    Article • Pharmaceuticals, March 2024, MDPI AG

    Tomaž Vovk

  12. Volumetric absorptive microsampling for the therapeutic drug monitoring of psychiatric patients treated with cariprazine

    Article • Journal of Pharmaceutical and Biomedical Analysis, November 2023, Elsevier

    Tomaž Vovk, Dr. Michele Protti, Professor Roberto Mandrioli

  13. Evaluation of antioxidant status and lipid peroxidation in dogs with myxomatous mitral valve degeneration stage B1

    Article • Frontiers in Veterinary Science, September 2023, Frontiers

    Tomaž Vovk

  14. THE EFFECT OF A SPECIFIC CHICKEN BASED RENAL DIET AS MONOTHERAPY ON CLINICAL, BIOCHEMICAL, URINARY AND SERUM OXIDATIVE STRESS PARAMETERS IN CATS WITH CKD STAGE 1 AND 2

    Article • Slovenian Veterinary Research, March 2023, University of Ljubljana

    Tomaž Vovk

  15. Potential Drug-Drug Interactions among Patients with Schizophrenia Spectrum Disorders: Prevalence, Association with Risk Factors, and Replicate Analysis in 2021

    Article • Medicina, February 2023, MDPI AG

    Tomaž Vovk

  16. Population pharmacokinetics of cisplatin in small cell lung cancer patients guided with informative priors

    Article • Cancer Chemotherapy and Pharmacology, August 2022, Springer Science + Business Media

    Tomaž Vovk

  17. Dried Volumetric Microsampling Approaches for the Therapeutic Drug Monitoring of Psychiatric Patients Undergoing Clozapine Treatment

    Article • Frontiers in Psychiatry, June 2022, Frontiers

    Dr. Michele Protti, Tomaž Vovk

  18. The Effect of Two Acute Bouts of Exercise on Oxidative Stress, Hematological, and Biochemical Parameters, and Rectal Temperature in Trained Canicross Dogs

    Article • Frontiers in Veterinary Science, March 2022, Frontiers

    Tomaž Vovk

  19. Ustekinumab Dosing Individualization in Crohn’s Disease Guided by a Population Pharmacokinetic–Pharmacodynamic Model

    Article • Pharmaceutics, September 2021, MDPI AG

    Tomaž Vovk, Erwin Dreesen

  20. Effects of Vitamin E and Coenzyme Q10 Supplementation on Oxidative Stress Parameters in Untrained Leisure Horses Subjected to Acute Moderate Exercise

    Article • Antioxidants, June 2021, MDPI AG

    Tomaž Vovk

  21. Evaluation of oxidative stress parameters in dogs with brachycephalic obstructive airway syndrome before and after surgery

    Article • Journal of Veterinary Research, May 2021, De Gruyter

    Tomaž Vovk

  22. The Evolving Role of Microsampling in Therapeutic Drug Monitoring of Monoclonal Antibodies in Inflammatory Diseases

    Article • Molecules, March 2021, MDPI AG

    Tomaž Vovk

  23. VAMS and StAGE as innovative tools for the enantioselective determination of clenbuterol in urine by LC-MS/MS

    Article • Journal of Pharmaceutical and Biomedical Analysis, February 2021, Elsevier

    Dr. Michele Protti, Associate Prof. Dr. Laura Mercolini, Tomaž Vovk

  24. Antioxidant capacity of lipid- and water-soluble antioxidants in dogs with subclinical myxomatous mitral valve degeneration anaesthetised with propofol or sevoflurane

    Article • BMC Veterinary Research, August 2020, Springer Science + Business Media

    Tomaž Vovk

  25. Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn’s Disease Likely to Achieve Endoscopic and Biochemical Remission

    Article • Clinical Gastroenterology and Hepatology, February 2020, Elsevier

    Erwin Dreesen, Tomaž Vovk

  26. Determination of 6-thioguanine and 6-methylmercaptopurine in dried blood spots using liquid chromatography-tandem mass spectrometry: Method development, validation and clinical application

    Article • Clinica Chimica Acta, December 2019, Elsevier

    Tomaž Vovk

  27. Influence of sevoflurane or propofol anaesthesia on oxidative stress parameters in dogs with early-stage myxomatous mitral valve degeneration. A preliminary study

    Article • Acta veterinaria, March 2018, De Gruyter

    Tomaž Vovk

  28. Curriculum Mapping of the Master’s Program in Pharmacy in Slovenia with the PHAR-QA Competency Framework

    Article • Pharmacy, May 2017, MDPI AG

    Dr Nejc Horvat, Tomaž Vovk

  29. Control of chemotherapy-induced nausea and vomiting in patients with gastrointestinal tumours

    Article • European Journal of Hospital Pharmacy, June 2016, BMJ

    Tomaž Vovk

  30. Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters

    Article • British Journal of Clinical Pharmacology, May 2016, Wiley

    Tomaž Vovk

  31. Bisoprolol pharmacokinetics and body composition in patients with chronic heart failure: a longitudinal study

    Article • European Journal of Clinical Pharmacology, March 2016, Springer Science + Business Media

    Professor Giuseppe M C Rosano, Tomaž Vovk

  32. Vitamin E and essential polyunsaturated fatty acids supplementation in schizophrenia patients treated with haloperidol

    Article • Nutritional Neuroscience, March 2016, Taylor & Francis

    Iztok Grabnar, Tomaž Vovk

  33. A simple dried blood spot method for clinical pharmacological analyses of etoposide in cancer patients using liquid chromatography and fluorescence detection

    Article • Clinica Chimica Acta, January 2016, Elsevier

    Tomaž Vovk

  34. Dried blood spots for monitoring and individualization of antiepileptic drug treatment

    Article • European Journal of Pharmaceutical Sciences, July 2015, Elsevier

    Tomaž Vovk

  35. Simple and sensitive high performance liquid chromatography method with fluorescence detection for therapeutic drug monitoring of topiramate

    Article • Acta Chimica Slovenica, June 2015, Slovenian Chemical Society

    Tomaž Vovk

  36. Febrile neutropenia in chemotherapy treated small-cell lung cancer patients

    Article • Radiology and Oncology, March 2015, De Gruyter

    Tomaž Vovk

  37. Antioxidants as a Preventive Treatment for Epileptic Process: A Review of the Current Status

    Article • Current Neuropharmacology, February 2015, Bentham Science Publishers

    Tomaž Vovk

  38. Simultaneous determination of gabapentin, pregabalin, vigabatrin, and topiramate in plasma by HPLC with fluorescence detection

    Article • Journal of Chromatography B, July 2014, Elsevier

    Tomaž Vovk

  39. Oxidative stress in schizophrenia patients treated with long-acting haloperidol decanoate

    Article • Psychiatry Research, December 2013, Elsevier

    Tomaž Vovk

  40. Population pharmacokinetics of topiramate in adult patients with epilepsy using nonlinear mixed effects modelling

    Article • European Journal of Pharmaceutical Sciences, November 2013, Elsevier

    Tomaž Vovk

  41. A Simple High-Throughput Method for Determination of Antiepileptic Analogues of γ-Aminobutyric Acid in Pharmaceutical Dosage Forms Using Microplate Fluorescence Reader

    Article • Chemical and Pharmaceutical Bulletin, January 2013, Pharmaceutical Society of Japan

    Tomaž Vovk

  42. Association of SOD2, GPX1, CAT, and TNF Genetic Polymorphisms with Oxidative Stress, Neurochemistry, Psychopathology, and Extrapyramidal Symptoms in Schizophrenia

    Article • Neurochemical Research, December 2012, Springer Science + Business Media

    Tomaž Vovk

  43. The Role of Reactive Species in Epileptogenesis and Influence of Antiepileptic Drug Therapy on Oxidative Stress

    Article • Current Neuropharmacology, December 2012, Bentham Science Publishers

    Tomaž Vovk

  44. Plasma malondialdehyde, biochemical and haematological parameters in standardbred horses during a selected field exercise test

    Article • Acta veterinaria, January 2012, National Library of Serbia

    Tomaž Vovk

  45. Oxidative Stress in Schizophrenia

    Article • Current Neuropharmacology, June 2011, Bentham Science Publishers

    Tomaž Vovk

  46. A Nonlinear Mixed Effects Modelling Analysis of Topiramate Pharmacokinetics in Patients with Epilepsy

    Article • Biological and Pharmaceutical Bulletin, January 2010, Pharmaceutical Society of Japan

    Prof Slobodan M Jankovic, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Tomaž Vovk

  47. Current clinical evidence on topiramate pharmacokinetics

    Article • Srpski arhiv za celokupno lekarstvo, January 2009, National Library of Serbia

    Prof Slobodan M Jankovic, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Tomaž Vovk

  48. Antioxidant Levels in the Pig Urinary Bladder: Distribution within the Bladder Wall and in the Urothelium Derived from Different Bladder Regions

    Article • Biological and Pharmaceutical Bulletin, January 2009, Pharmaceutical Society of Japan

    Tomaž Vovk

  49. Comparative study of robustness between micellar electrokinetic capillary chromatography and high-performance liquid chromatography using one-variable-at-a-time and a new multi-variable-at-a-time approach

    Article • Analytica Chimica Acta, July 2008, Elsevier

    Tomaž Vovk

  50. Sensitive electrochemical detection method for α-acids, β-acids and xanthohumol in hops (Humulus lupulus L.)

    Article • Journal of Chromatography B, May 2007, Elsevier

    Tomaž Vovk

  51. HPLC analysis of raloxifene hydrochloride and its application to drug quality control studies

    Article • Pharmacological Research, October 2005, Elsevier

    Tomaž Vovk

  52. Determination of main low molecular weight antioxidants in urinary bladder wall using HPLC with electrochemical detector

    Article • International Journal of Pharmaceutics, March 2005, Elsevier

    Tomaž Vovk

  53. The Correlation between Zeta Potential and Mucoadhesion Strength on Pig Vesical Mucosa

    Article • Biological and Pharmaceutical Bulletin, January 2003, Pharmaceutical Society of Japan

    Tomaž Vovk

  54. Antioxidative Properties of Pig Vesical Mucosa: A Comparison with Gastric and Intestinal Mucosa.

    Article • Biological and Pharmaceutical Bulletin, January 2001, Pharmaceutical Society of Japan

    Tomaž Vovk